You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine transporter gene

Showing 1 - 25 of 7,381
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Idiopathic Parkinson's Progression and Dopamine Transporter

Completed
  • Parkinson Disease
  • Ioflupane I 123
  • Lexington, Kentucky
    University of Kentucky Department of Neurology
Nov 16, 2022

Obesity Trial in Busan (Glucose injection/Normal saline injection)

Completed
  • Obesity
  • Glucose injection/Normal saline injection
  • Busan, Korea, Republic of
    Pusan National University Hospital
Apr 19, 2022

Non-motor Symptoms and Brain Dopamine Transporter Binding

Active, not recruiting
  • Parkinson Disease
  • Parkinsonism
  • DAT SPECT imaging
  • (no location specified)
Oct 12, 2021

Parkinson Disease Trial in New Haven (B-CIT and SPECT imaging)

Completed
  • Parkinson Disease
  • B-CIT and SPECT imaging
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Jul 1, 2022

Abiraterone Acetate, Gene Polymorphism, Pharmacokinetic Trial in Wuhan (Abiraterone acetate tablets)

Active, not recruiting
  • Abiraterone Acetate
  • +4 more
  • Abiraterone acetate tablets
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 30, 2021

Parkinson Disease, Movement Disorders Trial (Altropane (123I) Injection)

Not yet recruiting
  • Parkinson Disease
  • Movement Disorders
  • Altropane (123I) Injection
  • (no location specified)
Nov 23, 2022

es to Explore the Gene-Environment Interactions in ADHD

Unknown status
  • Monoamine Transporter Genes
  • Environmental Factors
    • Taipei, Taiwan
    • +1 more
    Oct 18, 2020

    Multiple System Atrophy Trial in Irvine, Columbus (AAV2-GDNF gene therapy, Sham (Placebo) Surgery)

    Recruiting
    • Multiple System Atrophy
    • AAV2-GDNF gene therapy
    • Sham (Placebo) Surgery
    • Irvine, California
    • +1 more
    Jan 18, 2023

    Treatment Resistant Depression Trial in Louisville (Discontinuation of serotonergic antidepressants, Continuation of

    Recruiting
    • Treatment Resistant Depression
    • Discontinuation of serotonergic antidepressants
    • Continuation of serotonergic medications
    • Louisville, Kentucky
      University of Louisville, Department of Psychiatry and Behaviora
    May 21, 2022

    Parkinson Disease Trial in Paris (Identification of COMT HH, COMT HL or COMT LL genes, Brain MRI with resting state scan, Brain

    Completed
    • Parkinson Disease
    • Identification of COMT HH, COMT HL or COMT LL genes
    • +2 more
    • Paris, France
      Groupe Hospitalier Pitié-Salpêtrière
    Feb 17, 2022

    ADHDs Trial in Vancouver (Psychostimulants)

    Active, not recruiting
    • Attention Deficit Hyperactivity Disorders
    • Vancouver, British Columbia, Canada
      Developmental Cognitive Neuroscience Lab, Department of Psychiat
    May 16, 2022

    Parkinson Disease Trial in Lund, Cambridge (STEM-PD)

    Recruiting
    • Parkinson Disease
    • STEM-PD
    • Lund, Sweden
    • +1 more
    Dec 7, 2022

    SLC13A5 Deficiency Natural History Study - Remote Only

    Recruiting
    • Citrate Transporter Deficiency
    • +9 more
      • Palo Alto, California
        Lucille Packard Children's Hospital, Stanford University
      Dec 22, 2020

      Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA) Trial in China (DaTSCAN™ Ioflupane (123I) Injection)

      Completed
      • Parkinsonian Syndrome
      • +3 more
      • DaTSCAN™ Ioflupane (123I) Injection
      • Beijing, Chaoyang District, China
      • +9 more
      Jun 20, 2022

      Parkinson's Disease Trial in Irvine, San Francisco, Columbus (AAV2-GDNF)

      Recruiting
      • Parkinson's Disease
      • AAV2-GDNF
      • Irvine, California
      • +2 more
      Feb 8, 2022

      Heart Failure, Cognitive Dysfunction Trial in Indianapolis (Nature-VR, Urban-VR)

      Active, not recruiting
      • Heart Failure
      • Cognitive Dysfunction
      • Nature-VR
      • Urban-VR
      • Indianapolis, Indiana
        Indiana University School of Nursing
      Aug 23, 2021

      Depression Trial in Philadelphia (drug, behavioral, procedure)

      Completed
      Has Results
      • Depression
      • Philadelphia, Pennsylvania
        Depression Research Unit - University of Pennsylvania
      Apr 3, 2020

      The Meaning of Dopaminergic Pathway in Sleep Breathing

      Enrolling by invitation
      • Sleep Apnea
      • Sleep-Disordered Breathing
      • Polysomnography
      • +2 more
      • Wroclaw, Poland
        Wroclaw Medical Uniwesity
      May 25, 2023

      ADHD, ADHD Trial in United States (Methylphenidate)

      Recruiting
      • ADHD
      • Attention Deficit Hyperactivity Disorder
      • Gainesville, Florida
      • +3 more
      Apr 5, 2022

      Post-traumatic Stress Disorder Trial (MRI using DaTscan)

      Not yet recruiting
      • Post-traumatic Stress Disorder
      • MRI using DaTscan
      • (no location specified)
      Oct 25, 2019

      Functional Relevance of Dopamine Receptors in Healthy Controls

      Recruiting
      • Schizoaffective Disorder
      • Schizophrenia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Creatine Transporter Defect Trial in Bron (Clinical endpoints, Parental questionnaires, Quality of life scale)

        Recruiting
        • Creatine Transporter Defect
        • Clinical endpoints
        • +9 more
        • Bron, France
          Woman, mother and child hospital, Hospices Civils de Lyon
        Aug 25, 2023

        Schizophrenia Trial in Erlangen (Quetiapine fumarate)

        Completed
        • Schizophrenia
        • Quetiapine fumarate
        • Erlangen, Germany
          Department of Psychiatry and Psychotherapy, University Erlangen-
        Dec 10, 2020